Exchange: NASDAQ·Updated 11:23 AM EDT
News
all
press releases
Here's Why HealthEquity (HQY) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
More News
HealthEquity (HQY) Q2 2027 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Why HealthEquity Stock Sank This Week
Key PointsHealthEquity posted significant sales and earnings beats with its fiscal Q2 report...
Nasdaq News: Markets
Crude Oil Moves Higher; Dollar General Shares Gain After Upbeat Q2 Earnings
U.S. stocks traded higher, Dow up 0.20%, NASDAQ up 1.05%, S&P 500 up 0.47%. Tech shares jumped 2.4% while consumer staples fell 1%. Dollar General gained 5% on strong earnings. Propanc Biopharma soared 157%. Okta and Veeva Systems also rose. Build-A-Bear Workshop and Healthequity fell on earnings...
Benzinga
HealthEquity Reports Q2 2027 Results: Full Earnings Call Transcript
HealthEquity (NASDAQ:HQY) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you by Benzingaread more...
Benzinga
HealthEquity (HQY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for HealthEquity (HQY) give a sense of how the business performed in the quarter ended July 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks
HealthEquity (HQY) Q2 Earnings and Revenues Top Estimates
HealthEquity (HQY) delivered earnings and revenue surprises of +4.20% and +0.14%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Ahead of HealthEquity (HQY) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Beyond analysts' top-and-bottom-line estimates for HealthEquity (HQY), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended July 2026.
Zacks
Biofrontera Inc. (BFRI) Reports Q2 Loss, Beats Revenue Estimates
Biofrontera Inc. (BFRI) delivered earnings and revenue surprises of +70.59% and +33.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Astrana Health, Inc. (ASTH) Q2 Earnings Top Estimates
Astrana Health, Inc. (ASTH) delivered earnings and revenue surprises of +29.03% and -0.85%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks

Advertisement|Remove ads.